Skip to main content
Equibles

CITIGROUP INC

Position in BHC — Bausch Health Companies Inc.

CIK 831001 NEW YORK, NY
Back to BHC Full portfolio

Position in BHC

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$371,518
-$767,217 QoQ
Shares Held
75,359
-64.3% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BHC Over Time

Shares Held

Position Value (USD)

Derivatives in BHC

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$1,529,000
PutShares
220,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $573,447,136 across 59 Drug Manufacturers - Specialty & Generic names. BHC ranks #36 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 262,200 $142,067,824
2 ZTS
Zoetis Inc.
 1,265,210 $90,917,989
3 TEVA
Teva Pharmaceutical Industries Ltd
 2,527,031 $85,615,809
4 VTRS
Viatris Inc
 4,360,444 $69,243,850
5 NBIX
Neurocrine Biosciences Inc
 179,076 $30,181,467
6 INDV
Indivior Pharmaceuticals, Inc.
 643,006 $26,382,535
7 LNTH
Lantheus Holdings, Inc.
 189,692 $21,044,429
8 HLN
Haleon plc
 1,507,538 $14,065,329

All Filings in BHC

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $371,518 75,359
2026-03-31 $1,138,735 210,877
2025-12-31 $1,430,747 205,863
2025-12-31 $1,529,000 220,000
2025-09-30 $962,023 149,151
2025-09-30 $1,419,000 220,000
2025-06-30 $1,465,200 220,000
2025-06-30 $2,741,408 411,623
2025-03-31 $73,712 11,393
2025-03-31 $1,423,400 220,000
2024-12-31 $455,140 56,469
2024-12-31 $1,773,200 220,000
2024-09-30 $816,000 100,000
2024-09-30 $58,286 7,143
2024-06-30 $697,000 100,000
2024-06-30 $85,654 12,289
2024-03-31 $160,327 15,111
2023-12-31 $94,491 11,782
2023-09-30 $171,139 20,820
2023-06-30 $96,128 12,016
2023-03-31 $5,690,119 702,484
2023-03-31 $2,286,630 282,300
2022-12-31 $380,360 60,567
2022-12-31 $471,628 75,100
2022-09-30 $3,649,218 529,640
2022-09-30 $14,496,560 2,104,000
2022-09-30 $6,928,584 1,005,600
2022-06-30 $1,946,073 232,784
2022-06-30 $4,807,836 575,100
2022-03-31 $5,085,562 222,563
2022-03-31 $1,375,570 60,200
2021-12-31 $12,145,639 439,900
2021-12-31 $24,710,950 895,000
2021-12-31 $1,169,254 42,349
2021-09-30 $5,570,000 200,000
2021-09-30 $5,725,960 205,600
2021-09-30 $682,462 24,505
2021-06-30 $10,533,180 359,249
2021-03-31 $4,642,894 146,279
2020-12-31 $2,506,400 120,500
2020-12-31 $4,580,160 220,200
2020-12-31 $9,130,886 438,985
2020-09-30 $3,672,102 236,300
2020-09-30 $4,924,935 316,920
2020-09-30 $4,191,138 269,700
2020-06-30 $6,097,189 333,362
2020-06-30 $4,221,332 230,800
2020-06-30 $4,109,763 224,700
2020-03-31 $2,642,750 170,500
2020-03-31 $3,582,050 231,100

Report a Problem

Category
Description
Email (optional, for follow-up)